The National Academies
Health and Medicine Division
Explore by Topic
Biomedical and Health Research
Children, Youth and Families
Food and Nutrition
Health Care Workforce
Health Services, Coverage, and Access
Military and Veterans Health
Quality and Patient Safety
Select Populations and Health Disparities
Substance Use and Mental Health
Displaying: 11 to 20 of 49 Meetings
International Regulatory Harmonization Amid Globalization of Biomedical Research & Medical Product Development
Date: February 13, 2013 - February 14, 2013 (8:30 AM Eastern)
This public workshop will address needs for international harmonization of regulatory standards to support the development, evaluation and surveillance of biomedical products. Specifically, the discussions at the workshop will help identify principles, potential approaches, and strategies to advance the development or evolution of more harmonized regulatory standards.
The Global Crisis of Drug-Resistant Tuberculosis and the Leadership of the BRICS Countries: Challenges and Opportunities
Date: January 16, 2013 - January 18, 2013 (7:00 AM Eastern)
The increasing burden of drug-resistant tuberculosis introduces new challenges to traditional TB control and treatment programs and calls upon the global health community to collaborate and share scientific information in new and different ways. This 3-day workshop is sponsored by the Forum on Drug Discovery, Development, and Translation of the U.S. National Academy of Sciences, Institute of Medicine (IOM) and the Institute of Microbiology of the Chinese Academy of Sciences (CAS). Following an inaugural meeting in Washington, D.C. in 2008, this workshop in Beijing is the fourth in a series of international workshops convened by the U.S. IOM. The objective of the workshop series is to realistically assess the impact of and challenges resulting from drug-resistant TB globally and in the four countries with the most people affected (China, India, Russia, and South Africa).
Large Simple Trials and Knowledge Generation in a Learning Health System
Date: November 26, 2012 - November 27, 2012 (1:00 PM Eastern)
The workshop will explore the opportunities and challenges associated with leveraging the rapid digitalization of health care to accelerate the use of large simple trials (LSTs), and the speed and practicality of knowledge generation for medical decision making and medical product development in a continuously learning health system.
IOM Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB
Date: July 31, 2012 - August 1, 2012 (8:00 AM Eastern)
Two-day workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB.
Maximizing the Goals of the Cures Acceleration Network to Accelerate the Development of New Drugs and Diagnostics: A Workshop
Date: June 4, 2012 - June 5, 2012 (8:30 AM Eastern)
This public workshop will consider options and opportunities to maximize the usefulness and impact of the CAN program in order to advance translational sciences. In addition to providing suggestions to NCATS, the workshop is, in part, in response to Congressional interest in CAN expressed in the FY 2012 appropriations act conference report.
Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020
Date: November 7, 2011 - November 8, 2011 (8:30 AM Eastern)
The Institute of Medicine will conduct a workshop that will explore issues related to Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020. More specifically, the workshop will: (1) frame the problem and discuss a vision for a clinical trials enterprise that is efficient and effective and fully integrated into the health delivery system of 2020; (2) define how the envisioned clinical trials enterprise differs from the current system and suggest approaches to transform our current system into a learning system; and (3) consider core themes in framing an agenda to effect transformation of the U.S. clinical trials enterprise, including the development of a robust clinical trials workforce, the alignment of cultural and financial incentives, and building an infrastructure to support a transformed clinical trials enterprise.
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: An Institute of Medicine Workshop
Date: September 20, 2011 - September 21, 2011 (8:30 AM Eastern)
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
Public Engagement in the U.S. Clinical Trial Enterprise-Collaboration with Mount Sinai Department of Health Evidence and Policy
Date: June 27, 2011 - June 28, 2011 (12:00 PM Eastern)
IOM Drug Forum and Mount Sinai School of Medicine Seek to engage stakeholders and experts in an open discussion of current challenges and potential solutions to improving the capacity for efficiently conducting clinical trials in the United States by enhancing public engagement.
Facing the Reality of Multidrug-Resistant Tuberculosis: Challenges and Potential Solutions in India
Date: April 18, 2011 - April 21, 2011 (9:00 AM Eastern)
Burden and profile of drug-resistant tuberculosis in India and globally; Preventing transmission of drug-resistant tuberculosis / infection control strategies
Advancing Regulatory Science for Medical Countermeasure Development - A Workshop
Date: March 29, 2011 - March 30, 2011 (8:00 AM Eastern)
In response to a request from the Food and Drug Administration (FDA), the Institute of Medicine will conduct a workshop that will explore issues related to Advancing Regulatory Science for Medical Countermeasure Development.